• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重指数对 COPD 死亡率的影响:一项更新的剂量-反应荟萃分析。

The impact of body mass index on mortality in COPD: an updated dose-response meta-analysis.

机构信息

Division of Respirology and Critical Care, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia

Indonesian Medical Education and Research Institute, Faculty of Medicine University of Indonesia, Jakarta, Indonesia.

出版信息

Eur Respir Rev. 2024 Nov 27;33(174). doi: 10.1183/16000617.0261-2023. Print 2024 Oct.

DOI:10.1183/16000617.0261-2023
PMID:39603663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11600125/
Abstract

BACKGROUND AND OBJECTIVE

The obesity paradox is a well-established clinical conundrum in COPD patients. This study aimed to provide an updated analysis of the relationship between body mass index (BMI) and mortality in this population.

METHODS

A systematic search was conducted through Embase, PubMed, and Web of Science. International BMI cut-offs were employed to define underweight, overweight and obesity. The primary outcome was all-cause mortality, and the secondary outcome was respiratory and cardiovascular mortality.

RESULTS

120 studies encompassed a total of 1 053 272 patients. Underweight status was associated with an increased risk of mortality, while overweight and obesity were linked to a reduced risk of mortality. A nonlinear U-shaped relationship was observed between BMI and all-cause mortality, respiratory mortality and cardiovascular mortality. Notably, an inflection point was identified at BMI 28.75 kg·m (relative risk 0.83, 95% CI 0.80-0.86), 30.25 kg·m (relative risk 0.51, 95% CI 0.40-0.65) and 27.5 kg·m (relative risk 0.76, 95% CI 0.64-0.91) for all-cause, respiratory and cardiovascular mortality, respectively, and beyond which the protective effect began to diminish.

CONCLUSION

This study augments the existing body of evidence by confirming a U-shaped relationship between BMI and mortality in COPD patients. It underscores the heightened influence of BMI on respiratory and cardiovascular mortality compared to all-cause mortality. The protective effect of BMI was lost when BMI values exceeded 35.25 kg·m, 35 kg·m and 31 kg·m for all-cause, respiratory and cardiovascular mortality, respectively.

摘要

背景和目的

肥胖悖论是 COPD 患者中一个公认的临床难题。本研究旨在对该人群中体重指数(BMI)与死亡率之间的关系进行最新分析。

方法

通过 Embase、PubMed 和 Web of Science 进行系统检索。采用国际 BMI 切点定义消瘦、超重和肥胖。主要结局是全因死亡率,次要结局是呼吸和心血管死亡率。

结果

共纳入 120 项研究,总计 1053272 例患者。消瘦与死亡率增加相关,而超重和肥胖与死亡率降低相关。BMI 与全因死亡率、呼吸死亡率和心血管死亡率之间呈非线性 U 型关系。值得注意的是,在 BMI 为 28.75kg·m(相对风险 0.83,95%CI 0.80-0.86)、30.25kg·m(相对风险 0.51,95%CI 0.40-0.65)和 27.5kg·m(相对风险 0.76,95%CI 0.64-0.91)时,全因、呼吸和心血管死亡率分别出现拐点,超过该点后保护作用开始减弱。

结论

本研究通过证实 COPD 患者 BMI 与死亡率之间呈 U 型关系,增加了现有证据。它强调了 BMI 对呼吸和心血管死亡率的影响高于全因死亡率。当 BMI 值分别超过全因、呼吸和心血管死亡率的 35.25kg·m、35kg·m 和 31kg·m 时,BMI 的保护作用丧失。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b47/11600125/014c2dae4dc9/ERR-0261-2023.07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b47/11600125/51f525bcc34f/ERR-0261-2023.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b47/11600125/4e1c60767d78/ERR-0261-2023.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b47/11600125/6c6f49558bea/ERR-0261-2023.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b47/11600125/42802b2b054d/ERR-0261-2023.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b47/11600125/73c5f45ae189/ERR-0261-2023.05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b47/11600125/d31f57da62f5/ERR-0261-2023.06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b47/11600125/014c2dae4dc9/ERR-0261-2023.07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b47/11600125/51f525bcc34f/ERR-0261-2023.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b47/11600125/4e1c60767d78/ERR-0261-2023.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b47/11600125/6c6f49558bea/ERR-0261-2023.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b47/11600125/42802b2b054d/ERR-0261-2023.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b47/11600125/73c5f45ae189/ERR-0261-2023.05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b47/11600125/d31f57da62f5/ERR-0261-2023.06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b47/11600125/014c2dae4dc9/ERR-0261-2023.07.jpg

相似文献

1
The impact of body mass index on mortality in COPD: an updated dose-response meta-analysis.体重指数对 COPD 死亡率的影响:一项更新的剂量-反应荟萃分析。
Eur Respir Rev. 2024 Nov 27;33(174). doi: 10.1183/16000617.0261-2023. Print 2024 Oct.
2
Mortality and amputation outcomes of infrainguinal bypass versus endovascular therapy based on body mass index.基于体重指数的股腘动脉旁路移植术与血管腔内治疗的死亡率和截肢结局
J Vasc Surg. 2025 Jul;82(1):193-204. doi: 10.1016/j.jvs.2025.02.013. Epub 2025 Feb 19.
3
Association Between Body Mass Index Changes and All-Cause Mortality in Parkinson's Disease.体重指数变化与帕金森病全因死亡率的关系。
J Parkinsons Dis. 2024;14(7):1441-1450. doi: 10.3233/JPD-240181.
4
Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure.慢性心力衰竭患者体重指数与全因死亡率、心血管死亡率及住院率关系的Meta分析
Am J Cardiol. 2015 May 15;115(10):1428-34. doi: 10.1016/j.amjcard.2015.02.024. Epub 2015 Feb 18.
5
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
6
Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis.肥胖与慢性肾脏病患者心血管和全因死亡率的关系:系统评价和荟萃分析。
Nephrol Dial Transplant. 2017 Mar 1;32(3):439-449. doi: 10.1093/ndt/gfw075.
7
Are Patients With Morbid Obesity at Increased Risk of Pulmonary Embolism or Proximal Deep Vein Thrombosis After Lower Limb Arthroplasty? A Large-database Study.肥胖症患者下肢关节置换术后发生肺栓塞或近端下肢深静脉血栓的风险是否增加?一项大数据库研究。
Clin Orthop Relat Res. 2024 Jan 1;482(1):115-124. doi: 10.1097/CORR.0000000000002742. Epub 2023 Jul 4.
8
Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.6至11岁超重或肥胖儿童治疗中的饮食、身体活动及行为干预措施
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD012651. doi: 10.1002/14651858.CD012651.
9
Body mass index and all-cause mortality in US stroke population: a cohort study.美国中风人群的体重指数与全因死亡率:一项队列研究。
BMC Neurol. 2025 Jul 1;25(1):259. doi: 10.1186/s12883-025-04277-3.
10
Body Mass Index and Lung Function in Hospitalized Severe AECOPD Patients: Investigating Nonlinear Associations and the Role of Hemoglobin.住院严重慢性阻塞性肺疾病急性加重期患者的体重指数与肺功能:探究非线性关联及血红蛋白的作用
Int J Chron Obstruct Pulmon Dis. 2025 May 1;20:1309-1320. doi: 10.2147/COPD.S521112. eCollection 2025.

引用本文的文献

1
Association of GLP1RAs with risk of chronic obstructive pulmonary disease: evidence from drug target Mendelian randomization.胰高血糖素样肽-1受体激动剂与慢性阻塞性肺疾病风险的关联:来自药物靶点孟德尔随机化的证据
Diabetol Metab Syndr. 2025 Jul 28;17(1):295. doi: 10.1186/s13098-025-01866-7.
2
Exploring the link: nutritional status and chronic obstructive pulmonary disease - insights from NHANES and clinical research.探索关联:营养状况与慢性阻塞性肺疾病——来自美国国家健康与营养检查调查(NHANES)及临床研究的见解
BMC Pulm Med. 2025 Jul 3;25(1):318. doi: 10.1186/s12890-025-03755-1.
3
Leveraging Subjective Parameters and Biomarkers in Machine Learning Models: The Feasibility of for Managing Emphysema Progression.

本文引用的文献

1
Development and validation of a nomogram model for mortality prediction in stable chronic obstructive pulmonary disease patients: A prospective observational study in the RealDTC cohort.稳定期慢性阻塞性肺疾病患者死亡率预测列线图模型的建立与验证:真实世界 COPD 诊疗数据队列研究。
J Glob Health. 2024 Feb 23;14:04049. doi: 10.7189/jogh.14.04049.
2
Longitudinal changes in respiratory reactance in patients with COPD: associations with longitudinal change in air-trapping, exacerbations, and mortality.慢性阻塞性肺疾病患者呼吸电抗的纵向变化:与气体陷闭、急性加重和死亡率的纵向变化的关联。
Respir Physiol Neurobiol. 2024 Apr;322:104216. doi: 10.1016/j.resp.2024.104216. Epub 2024 Jan 17.
3
在机器学习模型中利用主观参数和生物标志物:管理肺气肿进展的可行性
Diagnostics (Basel). 2025 May 3;15(9):1165. doi: 10.3390/diagnostics15091165.
4
Nutrition, Lifestyle, and Environmental Factors in Lung Homeostasis and Respiratory Health.肺部稳态与呼吸健康中的营养、生活方式及环境因素
Nutrients. 2025 Mar 9;17(6):954. doi: 10.3390/nu17060954.
5
Leptin and Insulin in COPD: Unveiling the Metabolic-Inflammatory Axis-A Narrative Review.慢性阻塞性肺疾病中的瘦素与胰岛素:揭示代谢-炎症轴——一篇叙述性综述
J Clin Med. 2025 Apr 10;14(8):2611. doi: 10.3390/jcm14082611.
6
Association of cardiovascular health with COPD (NHANES 2007-2020): mediating potential of lean body mass.心血管健康与慢性阻塞性肺疾病的关联(2007 - 2020年美国国家健康与营养检查调查):瘦体重的潜在中介作用
Front Endocrinol (Lausanne). 2025 Apr 4;16:1539550. doi: 10.3389/fendo.2025.1539550. eCollection 2025.
7
Therapeutic Management in Patients with Chronic Obstructive Pulmonary Disease Who Are Overweight or Obese: A Systematic Review and Meta-Analysis.超重或肥胖的慢性阻塞性肺疾病患者的治疗管理:一项系统评价和荟萃分析。
J Clin Med. 2025 Feb 13;14(4):1230. doi: 10.3390/jcm14041230.
COPD and Smoking Status - It Does Matter: Characteristics and Prognosis of COPD According to Smoking Status.
慢性阻塞性肺疾病与吸烟状况——至关重要:根据吸烟状况分析慢性阻塞性肺疾病的特征及预后
Chronic Obstr Pulm Dis. 2024 Jan 25;11(1):56-67. doi: 10.15326/jcopdf.2023.0433.
4
Lifestyle Intervention and Excess Weight in Chronic Obstructive Pulmonary Disease (COPD): INSIGHT COPD Randomized Clinical Trial.生活方式干预和慢性阻塞性肺疾病(COPD)中的超重问题:INSIGHT COPD 随机临床试验。
Ann Am Thorac Soc. 2023 Dec;20(12):1743-1751. doi: 10.1513/AnnalsATS.202305-458OC.
5
Differential impacts between fat mass index and fat-free mass index on patients with COPD.脂肪量指数和去脂体重指数对慢性阻塞性肺疾病患者的不同影响。
Respir Med. 2023 Oct;217:107346. doi: 10.1016/j.rmed.2023.107346. Epub 2023 Jun 28.
6
Early Desaturation During 6-Minute Walk Test is a Predictor of Mortality in COPD.6分钟步行试验期间的早期氧饱和度下降是慢性阻塞性肺疾病死亡率的一个预测指标。
Lung. 2023 Apr;201(2):217-224. doi: 10.1007/s00408-023-00613-x. Epub 2023 Apr 10.
7
Frailty and Mortality Risk in COPD: A Cohort Study Comparing the Fried Frailty Phenotype and Short Physical Performance Battery.COPD 患者的虚弱与死亡风险:比较 Fried 虚弱表型和简短体能测试的队列研究。
Int J Chron Obstruct Pulmon Dis. 2023 Jan 20;18:57-67. doi: 10.2147/COPD.S375142. eCollection 2023.
8
The impact of anemia on the mortality of COPD patients hospitalized for acute exacerbation resulting in respiratory failure.贫血对因急性加重导致呼吸衰竭而住院的慢性阻塞性肺疾病(COPD)患者死亡率的影响。
Monaldi Arch Chest Dis. 2022 Aug 9;93(2). doi: 10.4081/monaldi.2022.2254.
9
Cardiovascular disease in chronic obstructive pulmonary disease: a narrative review.慢性阻塞性肺疾病中的心血管疾病:一篇叙述性综述。
Thorax. 2022 Jun 30. doi: 10.1136/thoraxjnl-2021-218333.
10
Nomograms for Predicting Coexisting Cardiovascular Disease and Prognosis in Chronic Obstructive Pulmonary Disease: A Study Based on NHANES Data.列线图预测慢性阻塞性肺疾病合并心血管疾病及预后的研究:基于 NHANES 数据分析
Can Respir J. 2022 Jun 9;2022:5618376. doi: 10.1155/2022/5618376. eCollection 2022.